Financial Year |
March 31 2023 |
Monetary Funds |
500,787,836.33 |
Held-for-trading Financial Assets |
160,450,410.37 |
Notes Receivable |
-- |
Accounts Receivable |
222,790,074.05 |
Advances to Suppliers |
24,968,763.04 |
Other Receivables |
1,017,400.27 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
292,059,393.49 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
16,317,957.25 |
Total Current Assets |
1,265,032,946.00 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
5,690,462.44 |
Investment Properties |
-- |
Fixed Assetes |
1,432,054,884.70 |
Under-construction Projects |
321,037,631.43 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
251,447,329.95 |
R&D expenses |
-- |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
5,099,261.40 |
Deferred Income Tax Assets |
17,987,366.05 |
Other Non-Current Assets |
2,595,335.43 |
Sub-Total of Non-Current Assets |
2,035,912,271.40 |
Total Assets |
3,300,945,217.40 |
Short-Term Loans |
40,048,194.44 |
Trading Financial liabilities |
-- |
Notes Payable |
69,722,655.67 |
Accounts Payable |
156,909,537.19 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
10,697,839.61 |
Taxes Payable |
30,820,547.08 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
9,177,966.43 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
53,976,518.75 |
Other Current Liabilities |
595,867.07 |
Sub-Total of Current Liabilities |
379,566,809.79 |
Long-term Loans |
281,457,912.86 |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
7,402,233.60 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
366,052,617.73 |
Total Liabilities |
745,619,427.52 |
Paid-In Capital(Or Share Stock) |
588,700,000.00 |
Capital Surplus |
229,440,947.06 |
Surplus Reserve |
116,313,427.87 |
LESS:Treasury Stock |
262,415,185.16 |
Undistributed Profits |
1,883,286,600.11 |
Minority Stockholder's Interest |
-- |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,555,325,789.88 |
Owner's Equity(Stockholder's Equity) |
2,555,325,789.88 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
3,300,945,217.40 |